
    
      Conditions: Advanced pancreatic cancer subjects which were prospectively to receive
      first-line chemotherapy.

      Keywords: Advanced pancreatic cancer; paclitaxel liposome; S-1 Interventions: Drug:
      paclitaxel liposome; Drug:S-1 Phase: Phase IV Study Type: Interventional

      Study Design:

      Allocation: Non-randomized Endpoint Classification: Efficacy/ Safety Study Intervention
      Model: single arm Primary Purpose: Treatment MedlinePlus related topics: Cancer, Pancreatic
      Cancer Drug Information available for: paclitaxel liposome：paclitaxel liposome for injection
      S-1：Tegafur, Gimeracil and Oteracil Potassium Capsules

      Primary Outcome Measures:

      To evaluate the Progression Free Survival of patients with advanced pancreatic cancer after
      treated with paclitaxel liposome plus S-1.

      Secondary Outcome Measures:

      To evaluate the Overall Response Rate、overall survival、disease control rate、Quality of
      Life、adverse events of patients with advanced pancreatic cancer after treated with paclitaxel
      liposome plus S-1.
    
  